References
- Almeida IMC, Barreira JCM, Oliveira MBPP, Ferreira ICFR. Dietary antioxidant supplements: benefits of their combined use. Food Chem Toxicol 2011, 49, 3232-3237. https://doi.org/10.1016/j.fct.2011.09.012
- Blanchet J, Longpre F, Bureau G, Morissette M, DiPaolo T, Bronchti G, Martinoli MG. Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32, 1243-1250. https://doi.org/10.1016/j.pnpbp.2008.03.024
- Burns J, Yokota T, Ashihara H, Lean MEJ, Crozier A. Plant foods and herbal sources of resveratrol. J Agric Food Chem 2002, 50, 3337-3340. https://doi.org/10.1021/jf0112973
- Chao J, Li H, Cheng KW, Yu MS, Chang RCC, Wang M. Protective effects of pinostilbene, a resveratrol methylated derivative, against 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells. J Nutr Biochem 2010, 21, 482-489. https://doi.org/10.1016/j.jnutbio.2009.02.004
- Chao J, Yu MS, Ho YS, Wang M, Chang RCC. Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity. Free Radic Biol Med 2008, 45, 1019-1026. https://doi.org/10.1016/j.freeradbiomed.2008.07.002
- Deumens R, Blokland A, Prickaerts J. Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 2002, 175, 303-317. https://doi.org/10.1006/exnr.2002.7891
- Fremont L. Biological effects of resveratrol. Life Sci 2000, 66, 663-673 https://doi.org/10.1016/S0024-3205(99)00410-5
- Jin F, Wu Q, Lu YF, Gong QH, Shi JS. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. Eur J Pharmacol 2008, 600, 78-82. https://doi.org/10.1016/j.ejphar.2008.10.005
- Johnson WD, Morrissey RL, Usborne AL, Kapetanovic I, Crowell JA, Muzzio M, McCormick DL. Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity. Food Chem Toxicol 2011, 49, 3319-3327. https://doi.org/10.1016/j.fct.2011.08.023
- Lee MK, Kang SJ, Poncz M, Song KJ, Park KS. Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine. Exp Mol Med 2007, 39, 376-384. https://doi.org/10.1038/emm.2007.42
- Lu KT, Ko MC, Chen BY, Huang JC, Hsieh CW, Lee MC, Chiou RYY, Wung BS, Peng CH, Yang YL. Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. J Agric Food Chem 2008, 56, 6910-6913. https://doi.org/10.1021/jf8007212
- Martin HL, Teismann P. Glutathione-a review on its role and significance in Parkinson's disease. FASEB J 2009, 23, 3263-3272. https://doi.org/10.1096/fj.08-125443
- Okawara M, Katsuki H, Kurimoto E, Shibata H, Kume T, Akaike A. Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults. Biochem Pharmacol 2007, 73, 550-560 https://doi.org/10.1016/j.bcp.2006.11.003
- Orr CF, Rowe DB, Halliday GM. An inflammatory review of Parkinson's disease. Prog Neurobiol 2002, 68, 325-340. https://doi.org/10.1016/S0301-0082(02)00127-2
- Richard T, Pawlus AD, Iglesias ML, Pedrot E, Waffo-Teguo P, Merillon JM, Monti JP. Neuroprotective properties of resveratrol and derivatives. Ann N Y Acad Sci 2011, 1215, 103-108. https://doi.org/10.1111/j.1749-6632.2010.05865.x
Cited by
- Fucoidan attenuates 6-hydroxydopamine-induced neurotoxicity by exerting anti-oxidative and anti-apoptotic actions in SH-SY5Y cells vol.57, pp.1, 2017, https://doi.org/10.14405/kjvr.2017.57.1.1